for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
World News

Russia completes clinical trials of second potential COVID-19 vaccine - RIA

FILE PHOTO: Small toy figures are seen in front of a Covid-19 Vaccine logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

MOSCOW (Reuters) - Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.

The institute completed early-stage human trials, known as Phase II, earlier this month.

Reporting by Maria Kiselyova; Writing by Alexander Marrow; Editing by Gareth Jones

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up